Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Nordic Capital and Permira propose to buy Bavarian Nordic for DKK 19 billion, a 21% premium.

flag A consortium led by Nordic Capital and Permira has proposed to buy Danish biopharmaceutical company Bavarian Nordic for about DKK 19 billion, offering DKK 233 per share, a 21% premium. flag Bavarian Nordic's board and executives agree to tender their shares. flag If successful, the deal would delist the company from Nasdaq Copenhagen. flag The transaction, expected to close by end of 2025, is subject to regulatory approvals and other conditions.

5 Articles